Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Sponsors › Genomics: Clinical Implementation › Veracyte Genomic Classifier Test for Lung Disease Validated in Clinical Study

Veracyte Genomic Classifier Test for Lung Disease Validated in Clinical Study

Apr 02, 2019
|
staff reporter

NEW YORK (GenomeWeb) – A new study by Veracyte and collaborators demonstrates that the company’s Envisia genomic test can improve the diagnosis of patients being evaluated for interstitial lung disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

  2. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  3. CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon

  4. JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

  5. Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.